My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2018
FROM THE PRESIDENT
America’s Opioid Epidemic: The Important Role of Our Specialty

There is no shortage of issues gripping America’s attention today, but many ID clinicians face daily the consequences of the opioid epidemic. As a medical student during the 1980s in New York City, I learned about endocarditis as well as some HIV and HBV infections arising from patient struggles with addiction.

Read More

Paul Auwaerter, MD, MBA, FIDSA
IDSA President
TOP STORIES
ID Compensation: Highlights from 2017 Survey

Promoting the value of the ID specialty and ensuring that ID/HIV clinical care is fairly compensated are major priorities for IDSA.

Read More

New OFID Study Shows Consultation with ID Associated with Lower Patient Mortality for Some Drug Resistant Infections

When ID specialists were involved in the care of patients with certain kinds of drug-resistant infections, the patients’ 30-day mortality rates were about 50 percent lower, according to a new study published in Open Forum Infectious Diseases.

Read More

Championing the ID/HIV Workforce on Capitol Hill

During a recent briefing on Capitol Hill sponsored by IDSA, HIVMA, SHEA and PIDS, several Society members shared their insights on the essential contributions of ID and HIV physicians and scientists to patient care, public health and research, as well as policy recommendations to secure the future of this workforce.

Read More

Recognize the Accomplishments of Outstanding Colleagues

IDSA and HIVMA offer multiple opportunities to acknowledge members who have made significant contributions to the field of ID and who have achieved professional excellence. Nominate your colleagues today for the IDSA Society Awards as an excellent way to recognize their efforts and accomplishments. The deadline for nominations is April 1.

Read More

Journal Club
  • Rectal Chlamydia and Gonorrhea Screening in Women: Missed Opportunities Among Those at Risk
  • Success of a Large Rapid Start ART Program for People Newly Diagnosed with HIV in New Orleans
  • Postnatal CMV Infection Does Not Impact Developmental Outcomes
  • No Role for Adjunctive Rifampicin in Treatment of Staphylococcus aureus Bacteremia

Read More

Upcoming dates to remember


The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 3-7 in San Francisco, CA. See you there!

PATIENT CARE & SCIENCE
NIH All of Us Precision Medicine Research Prioritization Workshop
IDSA Weighs in On FDA Re-Classification of HIV/HCV Diagnostic Tests
POLICY & ADVOCACY
Former HIV Researcher and Clinician, Robert Redfield, MD, Appointed CDC Director
IDSA Board Goes to Washington: Amplify their Voices
GLOBAL ID
Trans-Atlantic AMR Meeting Covers Stewardship, Surveillance, Research & More
Stop TB Fellowship Opens Door to New Advocacy Opportunities
Science Speaks Covers CROI
EDUCATION & RESOURCES
ABIM Announces Knowledge Check-In Dates for ID
Texas Medical Students Use IDSA Foundation Funding to Aid Their Community
Infection Prevention and Control for US Healthcare Workers – A Free CME/CE Certified Series from CDC and Medscape Education
FROM THE PRESIDENT
America’s Opioid Epidemic: The Important Role of Our Specialty
TOP STORIES
ID Compensation: Highlights from 2017 Survey
New OFID Study Shows Consultation with ID Associated with Lower Patient Mortality for Some Drug Resistant Infections
Championing the ID/HIV Workforce on Capitol Hill
Recognize the Accomplishments of Outstanding Colleagues
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here